Please use this identifier to cite or link to this item: http://hdl.handle.net/11054/1783
Title: Global Impact of COVID-19 on Stroke Care and IV Thrombolysis.
Author: Nogueira, R.
Qureshi, M.
Abdalkader, M.
Martins, S.
Yamagami, H.
Qiu, Z.
Mansour, O.
Sathya, A.
Czlonkowska, A.
Tsivgoulis, G.
de Sousa, D.
Demeestere, J.
Mikulik, R.
Vanacker, P.
Siegler, J.
Korv, J.
Biller, J.
Liang, C.
Sangha, N.
Zha, A.
Czap, A.
Holmstedt, C.
Turan, T.
Ntaios, G.
Malhotra, K.
Tayal, A.
Loochtan, A.
Ranta, A.
Mistry, E.
Alexandrov, A.
Huang, D.
Yaghi, S.
Raz, E.
Sheth, S.
Mohammaden, M.
Frankel, M.
Lamou, E.
Aref, H.
Elbassiouny, A.
Hassan, F.
Menecie, T.
Mustafa, W.
Shokri, H.
Roushdy, T.
Sarfo, F.
Alabi, T.
Arabambi, B.
Nwazor, E.
Sunmonu, T.
Wahab, K.
Yaria, J.
Mohammed, H.
Adebayo, P.
Riahi, A.
Sassi, S.
Sahathevan, Ramesh
Institutional Author: SVIN COVID-19 Global Stroke Registry
Issue Date: 2021
Publication Title: Neurology
Volume: 96
Issue: 23
Start Page: e2824
End Page: e2838
Abstract: Objective: To measure the global impact of COVID-19 pandemic on volumes of IV thrombolysis (IVT), IVT transfers, and stroke hospitalizations over 4 months at the height of the pandemic (March 1 to June 30, 2020) compared with 2 control 4-month periods. Methods: We conducted a cross-sectional, observational, retrospective study across 6 continents, 70 countries, and 457 stroke centers. Diagnoses were identified by their ICD-10 codes or classifications in stroke databases. Results: There were 91,373 stroke admissions in the 4 months immediately before compared to 80,894 admissions during the pandemic months, representing an 11.5% (95% confidence interval [CI] -11.7 to -11.3, p < 0.0001) decline. There were 13,334 IVT therapies in the 4 months preceding compared to 11,570 procedures during the pandemic, representing a 13.2% (95% CI -13.8 to -12.7, p < 0.0001) drop. Interfacility IVT transfers decreased from 1,337 to 1,178, or an 11.9% decrease (95% CI -13.7 to -10.3, p = 0.001). Recovery of stroke hospitalization volume (9.5%, 95% CI 9.2-9.8, p < 0.0001) was noted over the 2 later (May, June) vs the 2 earlier (March, April) pandemic months. There was a 1.48% stroke rate across 119,967 COVID-19 hospitalizations. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was noted in 3.3% (1,722/52,026) of all stroke admissions. Conclusions: The COVID-19 pandemic was associated with a global decline in the volume of stroke hospitalizations, IVT, and interfacility IVT transfers. Primary stroke centers and centers with higher COVID-19 inpatient volumes experienced steeper declines. Recovery of stroke hospitalization was noted in the later pandemic months.
Description: Many Lau & Thomas Kraemer listed as co-investigators
URI: http://hdl.handle.net/11054/1783
DOI: https://doi.org/10.1212/WNL.0000000000011885
Internal ID Number: 01737
Health Subject: COVID-19
CORONAVIRUS
STROKE
THROMBOLYSIS
Type: Journal Article
Article
Appears in Collections:Research Output

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.